Who is Speaking
Our speaker programmes are carefully researched each year to ensure that delegates are exposed to the highest level of expertise. However, delegates not only benefit from the experience of our speakers, but also gain an insight into the experiences of other attendees – Q&A sessions and panel discussions are utilised to enable sharing of knowledge and facilitate idea exchange.
If you have a cutting edge case study or relevant presentation and would like to join the speaker panel at one of our events, please contact Stefanie Castellanos at s.castellanos@oxfordglobal.co.uk
2018 Drug Discovery Summit and Discovery Chemistry & Drug Design Congress Confirmed Speakers Include:
Magnus Walter, Chief Scientific Officer Global Neurodegeneration
Eli Lilly
Petr Vachal, Vice President Discovery Chemistry
MSD
Philip Tagari, Vice President Research
Amgen
Anna Maroney, Vice President, Head of Alliance Management
AbbVie
Thorsten Thormann, Senior Vice President New Product Discovery
LEO Pharma
Juergen Gamer, Vice President Business Development
Apogenix
Yolanda Chong, Vice President Biology
Recursion Pharmaceuticals
Nils Jakob Vest Hansen, Chief Executive Officer
Vipergen ApS
Alexander Alanine, Chief Operating Officer
Bactevo
Vivek K Vishnudas, Chief Technology Officer
Berg
Thomas Franch, Chief Scientific Officer
Nuevolution
Dmitry Samarsky, Chief Scientific Officer
Silence Therapeutics
Mark Throsby, Chief Scientific Officer
Merus BV
Christel Menet, Chief Scientific Officer
Confo Therapeutics
Hubert Haag, Director Lead Discovery – Global Sourcing & External Business Opportunities
Sanofi
Jag Heer, Director of Medicinal Chemistry
UCB
Mike Hann, GSK Senior Fellow & Director, Drug Design & Selection
GlaxoSmithKline
Rob Howes, Director Reagents and Assay Development, Discovery Sciences
AstraZeneca
Ray Kemper, Director Discovery and Investigative Toxicology
Vertex
Joel Klappenbach, Director, Applied Genomics
MSD
Malin Lemurell, Director of Medicinal Chemistry
AstraZeneca
Jing Li, Director of Pharmacology, Screening and Triage
MSD
Carl Petersson, Scientific Director Drug Disposition
Merck KGaA
Wei-Sheng Huang, Director of Discovery Chemistry
Takeda
Daniel Zwilling, Director of CNS Discovery
Circuit Therapeutics
Julie Selkirk, Associate Director Biology
Celgene
Georgios Stamatas, Research Associate Director
Johnson & Johnson
Nathan Brown, Head Cheminformatics
BenevolentAI
Jose Duca, Head, Computer-Aided Drug Discovery
Novartis
Christoph Dumelin, Laboratory Head
Novartis
Florian Fuchs, CBT Screening Sciences, Head Cellular Assays
Novartis
Tobias Gabriel, Head External Drug Discovery
Novartis
Anish Konkar, Cluster Head, GI Endocrinology & Obesity
Sanofi-Aventis
Amaury Fernández Montalván, Laboratory Head
Bayer
Gerhard Hessler, Head of Synthetic Molecular Design
Sanofi
Joerg Knaeblein, Head of CoLaborator, Berlin & Technology Scouting
Bayer
Ulrich Schopfer, Head Integrated Target and Lead Discovery
Novartis
Franz Schuler, Head Drug Disposition and Safety, Pharmaceutical Sciences
Roche
Alan Whitmore, Head of Discovery Biology
e-Therapeutics
Lutz Mueller, Distinguished Scientist
F. Hoffmann-La Roche
Phil Cox, Senior Principal Research Scientist, FBDD Chemistry Group Leader
AbbVie
Ye Che, Senior Principal Scientist
Pfizer
Hasane Ratni, Senior Principal Scientist
F. Hoffmann-La Roche
Jörg Bentzien, Principal Scientist
FORMA Therapeutics
Bart DeCorte, Principal Scientist
Johnson & Johnson
Peter Ellmark, Principal Scientist
Alligator Bioscience
Stefan Geschwinder, Principal Scientist
AstraZeneca
Mike Morrison, Principal Scientist
Epizyme
Jonathan Wingfield, Principal Scientist
AstraZeneca
Dan Blat, Senior Scientist Preclinical Biology
Immunocore Ltd.
Iulia Diaconu, Senior Scientist I
Bluebird Bio
Anthony Donofrio, Senior Scientist HTE and Lead Discovery Capabilities
MSD
Vineet Pande, Senior Scientist Molecular Informatics
Janssen
Davide Gianni, Team Leader Discovery Biology
AstraZeneca
Steve Andrews, Head of Chemistry
Cambridge Drug Discovery Institute
Paul Andrews, Director of Operations, National Phenotypic Screening Centre
University of Dundee
Rod Hubbard, Senior Fellow and Professor
Vernalis and University of York
Ernesto Freire, Henry Walters Professor
Johns Hopkins University
Jonathan Hall, Professor
ETH Zurich
Magnus Ingelman-Sundberg, Professor
Karolinska Institutet
Johannes Kirchmair, Professor of Applied Bioinformatics
University of Hamburg
Richard Meehan, Professor
Edinburgh University
Kristian Strømgaard, Professor, Director
University of Copenhagen
Paul Brennan, Associate Professor, Medicinal Chemistry
University of Oxford
Olivia Rossanese, Head of Biology and Reader
The Institute of Cancer Research
Fredrik Wermeling, Assistant Professor
Karolinska Institutet
Co-located 2018 Microbiome Discovery & Development Congress Confirmed Speakers Include:
Patrice Garnier, Chief Executive Officer
AMAbiotics
Veronika Oudova, Chief Executive Officer
S-Biomedic
Catherine O’Neill, Chief Executive Officer
SkinBio Therapeutics
Nikole Kimes, Founder and Vice President
Siolta Therapeutics
Lionel Breton, Global Director of Open Research
L’Oreal
Imke Mulder, Research Director
4D Pharma
Alexander Sulakvelidze, Executive Vice-President and Chief Scientific Officer
Intralytix
Colette Shortt, Regulatory Director, Global Franchise Organisation
J&J Consumer
Ross O. Youngs, Founder and CEO
Biosortia Pharmaceuticals
Sandrine Claus, Chief Scientific Officer
LNC Therapeutics
Follow us on